Managing the Older Adult Patient with HIV
Editat de Giovanni Guaraldi, Julian Falutz, Chiara Mussi, Ana Rita Silvaen Limba Engleză Paperback – 21 apr 2016
Preț: 338.11 lei
Preț vechi: 355.91 lei
-5% Nou
Puncte Express: 507
Preț estimativ în valută:
64.70€ • 68.07$ • 53.71£
64.70€ • 68.07$ • 53.71£
Carte tipărită la comandă
Livrare economică 13-18 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783319201306
ISBN-10: 3319201301
Pagini: 100
Ilustrații: XXII, 227 p. 20 illus., 16 illus. in color.
Dimensiuni: 127 x 203 x 13 mm
Greutate: 0.36 kg
Ediția:1st ed. 2016
Editura: Springer International Publishing
Colecția Adis
Locul publicării:Cham, Switzerland
ISBN-10: 3319201301
Pagini: 100
Ilustrații: XXII, 227 p. 20 illus., 16 illus. in color.
Dimensiuni: 127 x 203 x 13 mm
Greutate: 0.36 kg
Ediția:1st ed. 2016
Editura: Springer International Publishing
Colecția Adis
Locul publicării:Cham, Switzerland
V-ar putea interesa
-
Virus Hunt: The search for the origin of HIV/AIDsDorothy H. Crawford-18%Preț: 67.27 lei81.63 lei -
-24%Preț: 522.57 lei688.07 lei -
Nevirapine and the Quest to End Pediatric AIDSRebecca J. Anderson-5%Preț: 296.73 lei312.34 lei -
-5%Preț: 413.75 lei435.53 lei -
AIDS Drugs For All: Social Movements and Market TransformationsEthan B. KapsteinPreț: 260.31 lei -
The Social Psychology of HIV InfectionJohn B. Pryor-34%Preț: 527.45 lei793.28 lei -
-13%Preț: 346.41 lei400.41 lei -
HIV ProtocolsVinayaka R. Prasad-5%Preț: 702.73 lei739.71 lei -
HIV-1 Proteomics: From Discovery to Clinical ApplicationDavid R. M. Graham-15%Preț: 625.34 lei735.69 lei -
Recent Developments in AIDSAbby Calvin-5%Preț: 884.60 lei931.16 lei -
-5%Preț: 755.06 lei794.80 lei -
-5%Preț: 666.66 lei701.75 lei -
-5%Preț: 708.59 lei745.89 lei
Public țintă
Professional/practitionerCuprins
1. Introduction
References
2. Pathophysiology of HIV/AIDS
Key points
2.1 Immunodeficiency, immune activation, and chronic inflammation
2.2 HIV and immunosenescence
2.3 Evolving clinical profile
References
3. HIV associated non-AIDS conditions in patients aging with HIV
Key points
3.1 HIV-associated non-AIDS conditions versus comorbidities
References
4. Comorbid conditions and older adults with HIV
Key points
4.1 Multimorbidity 4.2 Accentuated versus accelerated aging
4.3 Aging versus aged
References
5. Frailty in HIV
Key points
5.1 Defining frailty
5.2 Measuring frailty
5.3 The utility of measuring frailty
5.4 Frailty in the context of HIV
References
6. Disability
Key points
6.1 Overview
6.2 Functional impairment and disability in patients with HIV
6.3 Tools to measure disability
6.4 Conclusion References
7. Geriatric syndromes
Key points
7.1 Definition
7.2 Falls
7.3. Delirium
7.4 Conclusion
References
8. HIV prevention and screening in older adults
Key points
8.1 Age-related risk factors
8.2. Barriers to prevention
8.3. Screening and counselling opportunities
References
9. Multidimensional geriatric assessment in older patients with HIV
Key points References
10. Antiretroviral treatment in older patients
Key points
10.1 When to start antiretroviral therapy
10.2 What to start
10.3 What to change
10.4 Future perspectives
References
11. HIV, aging, and polypharmacy
Key points
References
12. Nutrition and physical exercise in older patients with HIV
Key points
12.1 Overview
12.2 Assessment of risk of malnutrition
12.3 Intervention 12.4 Sarcopenic obesity
12.5 Physical exercise
12.6 Conclusion
References
13. Smoking cessation in patients with HIV
Key points
13.1 Pharmacological strategies to treat nicotine dependence
References
14. Self-management
Key points
References
References
2. Pathophysiology of HIV/AIDS
Key points
2.1 Immunodeficiency, immune activation, and chronic inflammation
2.2 HIV and immunosenescence
2.3 Evolving clinical profile
References
3. HIV associated non-AIDS conditions in patients aging with HIV
Key points
3.1 HIV-associated non-AIDS conditions versus comorbidities
References
4. Comorbid conditions and older adults with HIV
Key points
4.1 Multimorbidity 4.2 Accentuated versus accelerated aging
4.3 Aging versus aged
References
5. Frailty in HIV
Key points
5.1 Defining frailty
5.2 Measuring frailty
5.3 The utility of measuring frailty
5.4 Frailty in the context of HIV
References
6. Disability
Key points
6.1 Overview
6.2 Functional impairment and disability in patients with HIV
6.3 Tools to measure disability
6.4 Conclusion References
7. Geriatric syndromes
Key points
7.1 Definition
7.2 Falls
7.3. Delirium
7.4 Conclusion
References
8. HIV prevention and screening in older adults
Key points
8.1 Age-related risk factors
8.2. Barriers to prevention
8.3. Screening and counselling opportunities
References
9. Multidimensional geriatric assessment in older patients with HIV
Key points References
10. Antiretroviral treatment in older patients
Key points
10.1 When to start antiretroviral therapy
10.2 What to start
10.3 What to change
10.4 Future perspectives
References
11. HIV, aging, and polypharmacy
Key points
References
12. Nutrition and physical exercise in older patients with HIV
Key points
12.1 Overview
12.2 Assessment of risk of malnutrition
12.3 Intervention 12.4 Sarcopenic obesity
12.5 Physical exercise
12.6 Conclusion
References
13. Smoking cessation in patients with HIV
Key points
13.1 Pharmacological strategies to treat nicotine dependence
References
14. Self-management
Key points
References
Recenzii
“Guaraldi and colleagues have produced a concise review of ageing and HIV infection. … The focus of HIV care is shifting from immunodeficiency and opportunistic infections to age-related comorbidities. This informative resource allows practitioners in the field of HIV infection to familiarize themselves with current thinking in this area.” (Frank Post, British Journal of Hospital Medicine, Vol. 77 (9), September, 2016)
Notă biografică
Giovanni Guaraldi, MD, is Assistant Professor of Infectious disease at University of Modena and Reggio Emilia, Italy, where he also completed his medical training. Dr Guaraldi undertook his residency at Liverpool School of Tropical Medicine, UK, and Jackson Memorial Hospital, USA.
Dr Guaraldi was awarded the Dean's Delegate Cooperation for development projects of Modena University. He has extensive experience in HIV in resource limited countries and has coordinated the European Africa, Caribbean, Pacific project CoBaSys (Community Based System in HIV Treatment) focused on antiretroviral access programs in sub-Saharan African countries.
In 2002 Dr Guaraldi started a liver and kidney transplant program for people with HIV at the multivisceral transplant centre at Policlinico of Modena, Italy. Since the centre opened he has personally cared for approximately 80 patients with HIV who have received solid organ transplantation. Dr Guaraldi has lead the Modena HIV Metabolic Clinic since 2000. This referral centre cares for more than 4000 patients and offers a multidisciplinary team consisting of infectious disease physicians, nutritionists, occupational therapists, psychologists, cardiologists, nephrologists, endocrinologists, and plastic surgeons for the diagnosis and treatment of non-infectious comorbidities.
Dr Guaraldi has been the principal investigator in several studies generated by the MHMC, mainly focused on frailty and HIV associated comorbidities. He has extensive experience in scientific publication, with more than 260 peer reviewed papers, he is co-editor of Journal of Antimicrobial Chemotherapy, serves as reviewer for the major HIV journals, and as a consultant for EMA. He supervises PhD student in the Experimental Medicine PhD course at Modena University.
Dr Guaraldi is a panel member of the European AIDS Clinical Society guidelines on prevention and management of HIV associated comorbidities and has published widely on clinical aspects of HIV treatment and care.
Julian Falutz MD, FRCP(C), is Assistant Professor of Medicine at McGill University and Associate Physician at the Montreal General Hospital Site of the McGill University Hospital Centre (MUHC), Canada. He is the Director of the Comprehensive HIV and Aging Initiative in the Chronic Viral Illness Service and a Senior Physician in the Division of Geriatrics at the MUHC.
Dr Falutz attended McGill University School of Medicine, where he completed his residency in General Internal Medicine and received subspecialty training in both Internal Medicine and Geriatrics. He has been actively involved in the clinical care of both HIV and geriatric patients at the MUHC for over 25 years. He is active as a clinical teacher at the undergraduate and graduate levels and was the Director of the HIV elective program at the MUHC for 20 years.
His research in HIV has focused on the interaction of immunodeficiency, nutrition, and metabolic complications. He has initiated and participated in numerous studies on the management of HIV-related complications. He was the Co-Principal Investigator for the pivotal multinational studies investigating a novel Growth Hormone Releasing Factor for the treatment of abdominal obesity in patients with HIV. The investigated drug has since been approved for use in both the US and Canada. He is the Canadian Coordinator for the REPRIEVE Study, a multinational study of statins to prevent cardiovascular disease in low-risk treated HIV patients. He has initiated a Program for the evaluation of patients aging with HIV and plays an active role in emerging studies evaluating frailty and comorbidities in patients aging with HIV.
Chiara Mussi, MD, PhD, is a Doctor in Medicine within the Modena HIV Metabolic Clinic at the University of Modena and Reggio Emilia, Italy. Dr Mussi earned her medical degree from the University of Modena and Reggio Emilia in 1995, and her graduation thesis centred on orthostatic hypotension in the elderly. In 1999 Dr Mussi specialized in Geriatrics, and in 2004 she gained her PhD in Biology and Pathophysiology of Aging, where her main research topic was cardiovascular autonomic changes in older patients. In 2008 she obtained a research grant from the University of Modena and Reggio Emilia to research syncope in the elderly. Dr Mussi has been a researcher and Chair of Geriatrics at the University of Modena and Reggio Emilia since 2009. She also works as an MD at The New S Agostino-Estense Civil Hospital in Baggiovara, Modena.
Dr Mussi has authored more than 100 peer-reviewed papers published in international and national journals, is an expert in multidimensional geriatric evaluation and geriatric syndromes, and has been a consultant in the Multidisciplinary Expert Working Group dedicated to HIV aging population issues since 2013 (sponsored by ViiV Healthcare).
Ana Rita Silva, MD, is an Infectious Diseases Specialist in the Department of Infectious Diseases at the Hospital Beatriz Ângelo, Portugal. She works within the Infectious Diseases ward and is a consultant at the outpatient clinic. Dr Silva is currently undertaking her PhD in Clinical and Experimental Medicine at the University of Modena and Reggio Emilia, Italy, where Dr Giovanni Guaraldi and Dr Emília Valadas are her tutors.
Dr Silva attended the Coimbra School of Medicine (Faculdade de Medicina da Universidade de Coimbra) in Portugal, and started her residency in Infectious Diseases in 2008. In 2009, after attending a 3 month internship at the Clinica Metabolica, Dr Silva helped to create the Metabolic Consult at the Hospital de Joaquim Urbano, Portugal. Since 2009 she has been involved in several projects in the area of HIV and Aging, both in Portugal and with Dr Guaraldi in Italy, and has published several in this field. Dr Silva has also collaborated in the formation of residents and has participated as a lecturer in several courses, community actions, and congresses.
In 2013 she was awarded the certification in Travel Medicine by the International Society of Travel Medicine (ISTM) after taking the Certificate of Knowledge Examination. Throughout her career, Dr Silva has participated both as Principal and Co-investigator in several studies on HIV and HIV/Hepatitis C co-infection.
Dr Guaraldi was awarded the Dean's Delegate Cooperation for development projects of Modena University. He has extensive experience in HIV in resource limited countries and has coordinated the European Africa, Caribbean, Pacific project CoBaSys (Community Based System in HIV Treatment) focused on antiretroviral access programs in sub-Saharan African countries.
In 2002 Dr Guaraldi started a liver and kidney transplant program for people with HIV at the multivisceral transplant centre at Policlinico of Modena, Italy. Since the centre opened he has personally cared for approximately 80 patients with HIV who have received solid organ transplantation. Dr Guaraldi has lead the Modena HIV Metabolic Clinic since 2000. This referral centre cares for more than 4000 patients and offers a multidisciplinary team consisting of infectious disease physicians, nutritionists, occupational therapists, psychologists, cardiologists, nephrologists, endocrinologists, and plastic surgeons for the diagnosis and treatment of non-infectious comorbidities.
Dr Guaraldi has been the principal investigator in several studies generated by the MHMC, mainly focused on frailty and HIV associated comorbidities. He has extensive experience in scientific publication, with more than 260 peer reviewed papers, he is co-editor of Journal of Antimicrobial Chemotherapy, serves as reviewer for the major HIV journals, and as a consultant for EMA. He supervises PhD student in the Experimental Medicine PhD course at Modena University.
Dr Guaraldi is a panel member of the European AIDS Clinical Society guidelines on prevention and management of HIV associated comorbidities and has published widely on clinical aspects of HIV treatment and care.
Julian Falutz MD, FRCP(C), is Assistant Professor of Medicine at McGill University and Associate Physician at the Montreal General Hospital Site of the McGill University Hospital Centre (MUHC), Canada. He is the Director of the Comprehensive HIV and Aging Initiative in the Chronic Viral Illness Service and a Senior Physician in the Division of Geriatrics at the MUHC.
Dr Falutz attended McGill University School of Medicine, where he completed his residency in General Internal Medicine and received subspecialty training in both Internal Medicine and Geriatrics. He has been actively involved in the clinical care of both HIV and geriatric patients at the MUHC for over 25 years. He is active as a clinical teacher at the undergraduate and graduate levels and was the Director of the HIV elective program at the MUHC for 20 years.
His research in HIV has focused on the interaction of immunodeficiency, nutrition, and metabolic complications. He has initiated and participated in numerous studies on the management of HIV-related complications. He was the Co-Principal Investigator for the pivotal multinational studies investigating a novel Growth Hormone Releasing Factor for the treatment of abdominal obesity in patients with HIV. The investigated drug has since been approved for use in both the US and Canada. He is the Canadian Coordinator for the REPRIEVE Study, a multinational study of statins to prevent cardiovascular disease in low-risk treated HIV patients. He has initiated a Program for the evaluation of patients aging with HIV and plays an active role in emerging studies evaluating frailty and comorbidities in patients aging with HIV.
Chiara Mussi, MD, PhD, is a Doctor in Medicine within the Modena HIV Metabolic Clinic at the University of Modena and Reggio Emilia, Italy. Dr Mussi earned her medical degree from the University of Modena and Reggio Emilia in 1995, and her graduation thesis centred on orthostatic hypotension in the elderly. In 1999 Dr Mussi specialized in Geriatrics, and in 2004 she gained her PhD in Biology and Pathophysiology of Aging, where her main research topic was cardiovascular autonomic changes in older patients. In 2008 she obtained a research grant from the University of Modena and Reggio Emilia to research syncope in the elderly. Dr Mussi has been a researcher and Chair of Geriatrics at the University of Modena and Reggio Emilia since 2009. She also works as an MD at The New S Agostino-Estense Civil Hospital in Baggiovara, Modena.
Dr Mussi has authored more than 100 peer-reviewed papers published in international and national journals, is an expert in multidimensional geriatric evaluation and geriatric syndromes, and has been a consultant in the Multidisciplinary Expert Working Group dedicated to HIV aging population issues since 2013 (sponsored by ViiV Healthcare).
Ana Rita Silva, MD, is an Infectious Diseases Specialist in the Department of Infectious Diseases at the Hospital Beatriz Ângelo, Portugal. She works within the Infectious Diseases ward and is a consultant at the outpatient clinic. Dr Silva is currently undertaking her PhD in Clinical and Experimental Medicine at the University of Modena and Reggio Emilia, Italy, where Dr Giovanni Guaraldi and Dr Emília Valadas are her tutors.
Dr Silva attended the Coimbra School of Medicine (Faculdade de Medicina da Universidade de Coimbra) in Portugal, and started her residency in Infectious Diseases in 2008. In 2009, after attending a 3 month internship at the Clinica Metabolica, Dr Silva helped to create the Metabolic Consult at the Hospital de Joaquim Urbano, Portugal. Since 2009 she has been involved in several projects in the area of HIV and Aging, both in Portugal and with Dr Guaraldi in Italy, and has published several in this field. Dr Silva has also collaborated in the formation of residents and has participated as a lecturer in several courses, community actions, and congresses.
In 2013 she was awarded the certification in Travel Medicine by the International Society of Travel Medicine (ISTM) after taking the Certificate of Knowledge Examination. Throughout her career, Dr Silva has participated both as Principal and Co-investigator in several studies on HIV and HIV/Hepatitis C co-infection.
Caracteristici
A concise, practical handbook on the care of older patients with HIV, covering the pathophysiology, diagnosis, treatment, and comorbidities associated with this disease
Reviews the current treatment guidelines and recommendations for management of HIV in this subset of patients, and discusses the emerging treatments suitable for comorbid patients
Easily accessible text, tables, and images provide readers with a fast synopsis of key studies and available treatment options
Reviews the current treatment guidelines and recommendations for management of HIV in this subset of patients, and discusses the emerging treatments suitable for comorbid patients
Easily accessible text, tables, and images provide readers with a fast synopsis of key studies and available treatment options